Crystalloid Fluid Choice and Neurological Outcome in Patients After Subarachnoid Haemorrhage
Recruiting
N/A
Interventional Study
Subarachnoid Hemorrhage
Critical Illness
Infusion Fluid
Sodium Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 16 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 320 (estimated)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with subarachnoid hemorrhage are prone to suffer from dysnatriemia. Evidence shows that hyponatriemia is associated with increased incidence of vasospasm, brain swelling and mortality in these patients. Patients with subarachnoid hemorrhage often require large amounts of iv fluids in order to maintain euvolemia and support cardiocirculatory function. Prior evidence shows that the type of …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
All adult patients suffering from non-traumatic subarachnoid haemorrhage.
Exclusion Criteria:
* Patients with major intra-cranial trauma
* Diagnosis of an AV-malformation as the source of subarachnoid hemorrhage on the primary CT/MRI or angiography
* More than 24 hours after d…
Contacts